Why is Bafna Pharma. falling/rising?

As of 08-Aug, Bafna Pharmaceuticals Ltd is experiencing a price increase, currently at Rs 83.48, reflecting a rise of Rs 2.56 or 3.16%. Today's performance indicates that the stock has outperformed its sector by 4.32%, reaching an intraday high of Rs 87.72, which is an 8.4% increase. However, despite this positive movement, the stock has seen a decline of 2.33% over the past week and 2.28% over the past month. The delivery volume has decreased significantly by 32.45% compared to the 5-day average, suggesting a drop in investor participation. The stock's moving averages indicate it is currently above the 50-day, 100-day, and 200-day averages but below the 5-day and 20-day averages, which may reflect mixed investor sentiment.
In the broader market context, Bafna Pharmaceuticals' recent performance contrasts with the Sensex, which has declined by 0.92% over the past week and 4.60% over the past month. While the stock has shown a year-to-date gain of 9.12%, it has underperformed over the longer term, with a 3-year decline of 25.00% compared to the Sensex's gain of 35.69%. This suggests that while the stock is currently rising, it may still be facing challenges in regaining investor confidence in the longer term, especially given the falling delivery volumes and mixed moving averages.